J.F. Paitel

401 total citations
7 papers, 279 citations indexed

About

J.F. Paitel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, J.F. Paitel has authored 7 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Gastroenterology. Recurrent topics in J.F. Paitel's work include Gastrointestinal Tumor Research and Treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). J.F. Paitel is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). J.F. Paitel collaborates with scholars based in France and United States. J.F. Paitel's co-authors include Laurent Bedenne, Jean‐Luc Raoul, Gérard Lledo, Pierre Étienne, Marie Christine Kaminsky, Marc Giovannini, Philippe Rougier, Franck Bonnetain, Bruno Buecher and Chantal Milan and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Journal of Infection.

In The Last Decade

J.F. Paitel

6 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.F. Paitel France	5	226	166	106	62	27	7	279
Nanfeng Fan China	9	152 0.7×	112 0.7×	74 0.7×	53 0.9×	33 1.2×	22	238
Kazuhiko Shioji Japan	5	193 0.9×	109 0.7×	155 1.5×	74 1.2×	8 0.3×	11	280
Arinilda Campos Bragagnoli Brazil	6	131 0.6×	159 1.0×	94 0.9×	44 0.7×	26 1.0×	15	244
G. Schieppati Italy	7	117 0.5×	58 0.3×	50 0.5×	58 0.9×	27 1.0×	13	183
S. Tsousis Greece	6	134 0.6×	316 1.9×	65 0.6×	24 0.4×	27 1.0×	8	390
Sejung Park South Korea	10	151 0.7×	155 0.9×	120 1.1×	40 0.6×	32 1.2×	22	274
Hyung Geun Lee South Korea	9	236 1.0×	341 2.1×	334 3.2×	56 0.9×	16 0.6×	11	435
Mark Sievert Germany	4	165 0.7×	88 0.5×	94 0.9×	69 1.1×	12 0.4×	4	216
You-qing Zhan China	7	310 1.4×	79 0.5×	183 1.7×	127 2.0×	21 0.8×	12	386
Sanna Hulkki-Wilson United Kingdom	2	276 1.2×	163 1.0×	172 1.6×	106 1.7×	43 1.6×	4	366

Countries citing papers authored by J.F. Paitel

Since Specialization

Citations

This map shows the geographic impact of J.F. Paitel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Paitel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Paitel more than expected).

Fields of papers citing papers by J.F. Paitel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Paitel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Paitel. The network helps show where J.F. Paitel may publish in the future.

Co-authorship network of co-authors of J.F. Paitel

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Paitel. A scholar is included among the top collaborators of J.F. Paitel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Paitel. J.F. Paitel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Bidard, François‐Clément, Céline Callens, Florence Dalenc, et al.. (2020). Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.. Journal of Clinical Oncology. 38(15_suppl). 1010–1010. 36 indexed citations

Joly, Florence, Emmanuel Sevin, Alain Lortholary, et al.. (2009). Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial. Gynecologic Oncology. 116(3). 312–316. 6 indexed citations

André, Thierry, Pauline Afchain, Gérard Lledo, et al.. (2007). First-line simplified GEMOX (D1-D1) versus classical GEMOX (D1-D2) in metastatic pancreatic adenocarcinoma (MPA). A GERCOR randomized phase II study. Journal of Clinical Oncology. 25(18_suppl). 4592–4592. 1 indexed citations

Bouché, Olivier, Jean‐Luc Raoul, Franck Bonnetain, et al.. (2004). Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803. Journal of Clinical Oncology. 22(21). 4319–4328. 215 indexed citations

Raoul, Jean‐Luc, O. Bouché, Marco Giovannini, et al.. (2003). 46 Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): final results of study FFCD 9803. European Journal of Cancer Supplements. 1(5). S18–S18. 11 indexed citations

Paitel, J.F., Aline Guerci, Véronique Dorvaux, & P Lederlin. (1995). Septicémie à Yersinia enterocolitica, surcharge ferrique et déféroxamine. La Revue de Médecine Interne. 16(9). 705–707. 4 indexed citations

Dorvaux, Véronique, Thierry May, J.F. Paitel, et al.. (1995). Acute myelogenous leukaemia followed by non-Hodgkin's lymphoma in a patient with AIDS. Journal of Infection. 31(1). 69–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact